Catalys Pacific — 2024 Investments

1 investments dated 2024 · listed companies and verified rows first · show all

Pathalyspathalys.com in 𝕏Aug 2024 · $105M

Pathalys Pharma is a biotechnology company developing and improving therapeutic treatments for patients with chronic kidney disease.

BiotechHealthtechResearch Triangle Park, US

BT Slingsby(Co-Founder & Executive Chairman)in

Co-investorsAbingworth OrbiMed Samsara BioCapital KB Investment

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.